Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Comment on "An extracellular matrix fragment drives epithelial remodeling and airway hyperresponsiveness".

Penno CA, Wack N, Laguerre C, Hasler F, Numao S, Röhn TA.

Sci Transl Med. 2019 Jun 19;11(497). pii: eaav4538. doi: 10.1126/scitranslmed.aav4538.

PMID:
31217337
2.

Feasibility and physiological relevance of designing highly potent aminopeptidase-sparing leukotriene A4 hydrolase inhibitors.

Numao S, Hasler F, Laguerre C, Srinivas H, Wack N, Jäger P, Schmid A, Osmont A, Röthlisberger P, Houguenade J, Bergsdorf C, Dawson J, Carte N, Hofmann A, Markert C, Hardaker L, Billich A, Wolf RM, Penno CA, Bollbuck B, Miltz W, Röhn TA.

Sci Rep. 2017 Oct 19;7(1):13591. doi: 10.1038/s41598-017-13490-1.

3.

Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41.

Pastori C, Tudor D, Diomede L, Drillet AS, Jegerlehner A, Röhn TA, Bomsel M, Lopalco L.

Virology. 2012 Sep 15-30;431(1-2):1-11. doi: 10.1016/j.virol.2012.05.005. Epub 2012 Jun 2.

4.

A virus-like particle-based anti-nerve growth factor vaccine reduces inflammatory hyperalgesia: potential long-term therapy for chronic pain.

Röhn TA, Ralvenius WT, Paul J, Borter P, Hernandez M, Witschi R, Grest P, Zeilhofer HU, Bachmann MF, Jennings GT.

J Immunol. 2011 Feb 1;186(3):1769-80. doi: 10.4049/jimmunol.1000030. Epub 2010 Dec 29.

5.

IL-17A/F-signaling does not contribute to the initial phase of mucosal inflammation triggered by S. Typhimurium.

Songhet P, Barthel M, Röhn TA, Van Maele L, Cayet D, Sirard JC, Bachmann M, Kopf M, Hardt WD.

PLoS One. 2010 Nov 23;5(11):e13804. doi: 10.1371/journal.pone.0013804.

6.

Vaccines against non-communicable diseases.

Röhn TA, Bachmann MF.

Curr Opin Immunol. 2010 Jun;22(3):391-6. doi: 10.1016/j.coi.2010.02.009. Epub 2010 Mar 24. Review.

PMID:
20338740
7.

Transport of Streptococcus pneumoniae capsular polysaccharide in MHC Class II tubules.

Stephen TL, Fabri M, Groneck L, Röhn TA, Hafke H, Robinson N, Rietdorf J, Schrama D, Becker JC, Plum G, Krönke M, Kropshofer H, Kalka-Moll WM.

PLoS Pathog. 2007 Mar;3(3):e32.

8.

Vaccination against IL-17 suppresses autoimmune arthritis and encephalomyelitis.

Röhn TA, Jennings GT, Hernandez M, Grest P, Beck M, Zou Y, Kopf M, Bachmann MF.

Eur J Immunol. 2006 Nov;36(11):2857-67.

9.

Neutralization of IL-17 by active vaccination inhibits IL-23-dependent autoimmune myocarditis.

Sonderegger I, Röhn TA, Kurrer MO, Iezzi G, Zou Y, Kastelein RA, Bachmann MF, Kopf M.

Eur J Immunol. 2006 Nov;36(11):2849-56.

10.

A novel strategy for the discovery of MHC class II-restricted tumor antigens: identification of a melanotransferrin helper T-cell epitope.

Röhn TA, Reitz A, Paschen A, Nguyen XD, Schadendorf D, Vogt AB, Kropshofer H.

Cancer Res. 2005 Nov 1;65(21):10068-78.

11.

Melanoma cell necrosis facilitates transfer of specific sets of antigens onto MHC class II molecules of dendritic cells.

Röhn TA, Schadendorf D, Sun Y, Nguyen XD, Roeder D, Langen H, Vogt AB, Kropshofer H.

Eur J Immunol. 2005 Oct;35(10):2826-39.

12.

Upregulation of the CLIP self peptide on mature dendritic cells antagonizes T helper type 1 polarization.

Röhn TA, Boes M, Wolters D, Spindeldreher S, Müller B, Langen H, Ploegh H, Vogt AB, Kropshofer H.

Nat Immunol. 2004 Sep;5(9):909-18. Epub 2004 Aug 22.

PMID:
15322540
13.

Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.

Kropshofer H, Spindeldreher S, Röhn TA, Platania N, Grygar C, Daniel N, Wölpl A, Langen H, Horejsi V, Vogt AB.

Nat Immunol. 2002 Jan;3(1):61-8. Epub 2001 Dec 17.

PMID:
11743588
14.

CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c release.

Röhn TA, Wagenknecht B, Roth W, Naumann U, Gulbins E, Krammer PH, Walczak H, Weller M.

Oncogene. 2001 Jul 12;20(31):4128-37.

Supplemental Content

Support Center